Literature DB >> 11770171

Thalidomide, drug safety and early drug regulation in the UK.

R R Shah1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770171

Source DB:  PubMed          Journal:  Adverse Drug React Toxicol Rev        ISSN: 0964-198X


× No keyword cloud information.
  7 in total

Review 1.  Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

2.  The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector.

Authors:  A A Amin; R W Snow; G O Kokwaro
Journal:  J Clin Pharm Ther       Date:  2005-12       Impact factor: 2.512

Review 3.  Antimalarial drug quality in Africa.

Authors:  A A Amin; G O Kokwaro
Journal:  J Clin Pharm Ther       Date:  2007-10       Impact factor: 2.512

Review 4.  Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidance.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.

Authors:  Rashmi R Shah; Peter D Stonier
Journal:  Ther Adv Drug Saf       Date:  2018-06-18

Review 6.  Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines.

Authors:  Peter K Kaiser; Alan F Cruess; Peter Bogaert; Kamlesh Khunti; Simon P Kelly
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-12       Impact factor: 3.117

7.  Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics.

Authors:  Rashmi R Shah
Journal:  Drug Saf Case Rep       Date:  2017-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.